Review
Copyright ©The Author(s) 2024.
World J Virol. Sep 25, 2024; 13(3): 95349
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.95349
Table 2 Correlation of vitamin D concentrations with severe acute respiratory syndrome coronavirus 2 infections and outcomes
Ref.
n
Population type
Study type
Vitamin D dosages
Results
Lau et al[111], 202020Adults, average age 65.2 yrRetrospective observational studyNAHigher levels of vitamin D deficiency were observed in ICU patients (84.6%) compared to baseline patients (57.1%) (P = 0.29)
Hastie et al[115], 2020449Adults, age 37–73 yrCross-sectional studyNAVitamin D levels showed a significant association with SARS-CoV-2 infection in univariate analysis (P = 0.013)
IIie et al[116], 2020Cases and deaths/1 M populationAdultsRetrospectiveNANegative correlation was observed between mean levels of vitamin D and COVID-19 cases (P = 0.050) and deaths (P = 0.053) per million population
Glicio et al[117], 2020176Adults, age ≥ 60 yrRetrospectiveNASevere patients are more likely than mild patients had a lower level of vitamin D
Tan et al[69], 202043Adults, age ≥ 50 yrCohort observationalVitamin D 1000 IUPatients treated with vitamin D showed a significant protective effect against clinical deterioration after adjusting for age, sex and comorbidities (P = 0.041)
Darling et al[118], 2020580 cases and 723 controlsAdults, average age 57.7 yrRetrospectiveNANo significant difference was observed in vitamin D levels between COVID-19 cases and the control group
Raharusun et al[119], 2020780 casesAdults, average age 54.5 yrRetrospective cohort studyNAIn univariate analysis, older and male cases with pre-existing medical conditions and below normal vitamin D levels were associated with higher mortality rates
Daneshkhah et al[120], 2020 5000 casesAge ≤ 80 yrAs of March 21, 2020NAApproximately 15% reduction in the number of severe COVID-19 cases was observed in a population given a normal vitamin D status